Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2021

Chen B-, Wang Y, Shen Z-, Bennett A, Hindi I, Tyler JK, et al. The RNF8 and RNF168 Ubiquitin Ligases Regulate Pro- and Anti-Resection Activities at Broken DNA Ends During Non-Homologous End Joining. DNA Repair (Amst). 2021;108:103217.

Fujii T, Murata K, Mun S-, Bae S, Lee YJ, Pannellini T, et al. MEF2C regulates osteoclastogenesis and pathologic bone resorption via c-FOS. Bone Res. 2021;9(1):4.

Imada EL, Strianese D, Edward DP, alThaqib R, Price A, Arnold A, et al. RNA-sequencing highlights differential regulated pathways involved in cell cycle and inflammation in orbitofacial neurofibromas. Brain Pathol. 2021:e13007.

Duska LR, Filiaci VL, Walker JL, Holman LL, Hill EK, Moore RG, et al. A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular Response. Clin Cancer Res. 2021;27(10):2734-2741.

Shepherd NA, Yantiss RK. Histopathology annual review edition for 2021. Histopathology. 2021;78(1):2-3.

Weiner AB, Vidotto T, Liu Y, Mendes AA, Salles DC, Faisal FA, et al. Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes. Nat Commun. 2021;12(1):935.

Swed B, Gandarilla O, Chiu K, Halazun KH, Samstein B, Yantiss R, et al. Rare Histological Variants of Liver Cancer and Their Management: A Single-Institution Experience. Case Reports Hepatol. 2021;2021:6654229.

Cacciapuoti MT, Cappelli LV, Fiore D, Toruno P, Kayembe C, Tam W, et al. In Vivo and Ex Vivo Patient-Derived Tumor Xenograft Models of Lymphoma for Drug Discovery. Curr Protoc. 2021;1(4):e96.

Jurgens EM, Ketas TJ, Zhao Z, Satlin MJ, Small CB, Sukhu A, et al. Serologic response to mRNA COVID-19 vaccination in lymphoma patients. Am J Hematol. 2021;96(11):E410-E413.

Carrot-Zhang J, Yao X, Devarakonda S, Deshpande A, Damrauer JS, Silva TC, et al. Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway. Cell Rep. 2021;34(8):108784.